Modified coronavirus spike antigen protein and uses thereof
AssigneeRpexBio, Inc.
InventorsJong-Won OH, Hae-Gwang JUNG, Han Young SEO
Life of this patent
Estimating the term…
Abstract
There is a modified coronavirus spike antigen protein and uses therefor. The spike antigen protein of coronavirus exhibits suppression of cell membrane fusion ability and improves safety by modifying two protein cleavage sites present in the coronavirus spike protein. In addition, inoculation with a vaccine having the antigen protein induces production of a large number of neutralizing antibodies to inhibit invasion of coronavirus into cells, thereby suppressing viral proliferation.
Claims12
A spike antigen protein of coronavirus, in which a host protease cleavage site of the spike protein of coronavirus is modified.
11-17. (canceled)
Dependencies are inferred from the claim text.